Grants per year
Personal profile
Certifications and Licenses
| Clinical Pathology |
Training Experience
| 2009 | Residency, Northwestern University, Feinberg School of Medicine |
| 2013 | Postdoctoral Fellowship, Northwestern University Feinberg School of Medicine |
| 2014 | Fellowship, Northwestern University, Feinberg School of Medicine |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MD, PhD, Immunology, University of Iowa
… → 2005
Fingerprint
Dive into the research topics where Kristy Lucile Wolniak is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 2 Finished
-
Anti-PDL1 therapy for patients with Myelofibrosis
Stein, B. L. (PD/PI), Wainwright, D. A. (Co-Investigator) & Wolniak, K. L. (Co-Investigator)
MPN Research Foundation and the Leukemia & Lymphoma Society
8/1/16 → 5/22/17
Project: Research project
-
Core B Precision and Isolation Analysis
Chen, Q. C. (PD/PI) & Wolniak, K. L. (Subproject PI)
National Institute of Allergy and Infectious Diseases
7/1/15 → 12/31/20
Project: Research project
-
Challenging diagnosis of haemophagocytic lymphohistiocytosis secondary to T-cell/histiocyte-rich large B-cell lymphoma
Wautlet, A., Khojah, A. M., Wolniak, K. & Patel, G., Mar 13 2025, In: BMJ case reports. 18, 3, e261845.Research output: Contribution to journal › Article › peer-review
-
Correction to: “Accelerated” chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): unraveling the biological gray zone of CLL/SLL in the era of novel therapies (Virchows Archiv, (2025), 486, 4, (739-750), 10.1007/s00428-024-03920-7)
Vadasz, B., Zak, T., Aldinger, J., Sukhanova, M., Gao, J., Wolniak, K. L., Chen, Y. H., Chen, Q. C., Ma, S. & Tariq, H., Apr 2025, In: Virchows Archiv. 486, 4, p. 891 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Usefulness of Flow Cytometry Monocyte Partitioning in the Diagnosis of Chronic Myelomonocytic Leukemia in a Real-World Setting
Liu, Y., Tariq, H., Fu, L., Gao, J., Jagtiani, T., Wolniak, K., Aqil, B., Ji, P., Chen, Y.-H. & Chen, Q. C., Apr 2025, In: Cancers. 17, 7, 1229.Research output: Contribution to journal › Article › peer-review
Open Access -
“Accelerated” chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): unraveling the biological gray zone of CLL/SLL in the era of novel therapies
Vadasz, B., Zak, T., Aldinger, J., Sukhanova, M., Gao, J., Wolniak, K. L., Chen, Y. H., Chen, Q. C., Ma, S. & Tariq, H., Apr 2025, In: Virchows Archiv. 486, 4, p. 739-750 12 p., a035220.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/CBFB::MYH11
Gao, J., Santana-Santos, L., Fu, L., Alvey, E., Chen, Q., Wolniak, K., Xia, Z., Aqil, B., Behdad, A., Ji, P., Sukhanova, M., Abaza, Y., Altman, J. K., Chen, Y. H. & Lu, X., Jun 2024, In: European Journal of Haematology. 112, 6, p. 964-974 11 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations
Datasets
-
Virtual Pathology Elective Provides Uninterrupted Medical Education and Impactful Pathology Education During the COVID-19 Pandemic
Fu, L. (Creator), Swete, M. (Creator), Selgrade, D. (Creator), Chan, C. W. (Creator), Rodriguez, R. (Creator), Wolniak, K. (Creator) & Blanco, L. Z. (Creator), SAGE Journals, 2021
DOI: 10.25384/sage.c.5417455.v1, https://sage.figshare.com/collections/Virtual_Pathology_Elective_Provides_Uninterrupted_Medical_Education_and_Impactful_Pathology_Education_During_the_COVID-19_Pandemic/5417455/1
Dataset
-
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation
Abdel-Wahab, O. (Contributor), Lu, C. (Contributor), Patel, J. (Contributor), Shih, A. (Contributor), Li, Y. (Contributor), Bhagwat, N. (Contributor), Vasanthakumar, A. (Contributor), Sun, Z. (Contributor), Wolniak, K. (Contributor), Liu, W. (Contributor), Paietta, E. (Contributor), Löwenberg, B. (Contributor), Delwel, R. (Contributor) & Melnick, A. (Contributor), ArrayExpress, 2010
https://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-24505
Dataset